A novel
2-nitroimidazole with a
theophylline side-chain, 7-(4'-(2-nitroimidazol-1-yl)-butyl)-theophylline, (
NITP) was as efficient a hypoxic-cell radiosensitizer as
misonidazole. However, if cells were irradiated with
NITP under hypoxic conditions and then exposed to the
drug under aerobic conditions, a much larger
radiosensitizing effect was observed, partly because of a reduction in the size of the shoulder of the survival curve. There was little effect of
NITP on the radiosensitivity of well oxygenated cells, even with post-irradiation
drug contact. Split-dose survival curves showed that the
drug inhibited recovery from radiation damage only when the cells were irradiated under
hypoxia but not when irradiations were under oxic conditions. A reduction in the size of the shoulder of the survival curve should allow the hypoxic-cell radiosensitizing efficiency of
NITP to be maintained with low doses of radiation used in multifraction
cancer radiotherapy. Bifunctional drugs containing both electron-affinic and repair inhibiting groups may represent a new approach to the synthesis of hypoxic-cell targeted adjuncts to
radiotherapy.